Maternal high-fat diet disrupts intestinal mucus barrier of offspring by regulating gut immune receptor LRRC19

Yue Sun1,2, Shumin Huang1, Mengfan Li1

  • 1Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Key Medical Discipline (Specialty), Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, 300052, China.

Communications Biology
|March 13, 2025
PubMed

Insights

Maternal high-fat diet impairs offspring gut mucus barrier via LRRC19. Deleting leucine-rich repeat C19 (LRRC19) restores barrier function and beneficial bacteria, suggesting a novel therapeutic target.

Area of Science:

  • Immunology
  • Microbiology
  • Gastroenterology

Background:

  • Maternal high-fat diet (MHFD) increases offspring susceptibility to colitis.
  • The underlying mechanisms for MHFD-induced gut dysfunction remain unclear.

Purpose of the Study:

  • To investigate the role of the gut immune receptor leucine-rich repeat C19 (LRRC19) in MHFD-induced gut barrier impairment.
  • To explore the impact of LRRC19 on gut immune response and microbiota composition in offspring exposed to MHFD.

Main Methods:

  • Mice were exposed to MHFD during gestation.
  • Intestinal mucus barrier integrity, LRRC19 expression, gut microbiota composition (metagenome sequencing), and targeted metabolomics were analyzed.
  • Lrrc19 knockout (Lrrc19-/-) mice were used to assess the protective effects of LRRC19 deletion.

Main Results:

  • MHFD significantly impaired the intestinal mucus barrier and upregulated LRRC19 expression in offspring.
  • Lrrc19 deletion alleviated mucus barrier disruption and partially restored MHFD-induced gut microbiota alterations.
  • Lrrc19-/- offspring showed increased Akkermansia muciniphila and Lactobacillus reuteri, a producer of indole-3-acetic acid (IAA).
  • IAA improved mucus barrier function by enhancing IL-22+ ILC3 cells via the AhR pathway.

Conclusions:

  • MHFD disrupts the offspring intestinal mucus barrier by regulating the gut immune receptor LRRC19.
  • Imbalances in gut microbiota and metabolites, particularly IAA, play a crucial role in MHFD-induced gut dysfunction.
  • Targeting LRRC19 and modulating gut microbiota-derived metabolites like IAA may offer therapeutic strategies against MHFD-related gut issues.